Ischemic stroke risk with oral contraceptives: A meta-analysis.
about
Combined oral contraceptives: the risk of myocardial infarction and ischemic strokeEstrogen protects against the synergistic toxicity by HIV proteins, methamphetamine and cocaineMeta-analysis: neither quick nor easyRisk factors of transient ischemic attack: An overviewChoosing a combined oral contraceptive pillSex differences in predictors of ischemic stroke: current perspectivesRevisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for strokeRegarding "meta-analysis and causal inference: a case study of benzene and non-Hodgkin lymphoma": an incomplete analysisComparison of pooled risk estimates for adverse effects from different observational study designs: methodological overviewHeart disease and stroke statistics--2011 update: a report from the American Heart AssociationHeart disease and stroke statistics--2014 update: a report from the American Heart AssociationHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationHormonal Contraceptives and Migraine With Aura-Is There Still a Risk?A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease riskPrevention opportunities for oral contraceptive-associated ischemic stroke.Sex-specific responses to stroke.Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview.Clinical pharmacology and vascular risk.Systematic review of methods used in meta-analyses where a primary outcome is an adverse or unintended eventOral contraceptive use and mortality after 36 years of follow-up in the Nurses' Health Study: prospective cohort studySex differences in stroke case fatality: a meta-analysis.Female reproductive factors and primary open-angle glaucoma in the Nurses' Health StudyWhy might statins prevent venous thromboembolism: what needs to be done to know more?Estrogen and neuroprotection: from clinical observations to molecular mechanisms.Positive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days.Preventing a second stroke in the young.Inherited thrombophilia and stratification of ischaemic stroke risk among users of oral contraceptivesSex differences in stroke.Stroke risk in women: the role of menopause and hormone therapy.Contraindications to combined oral contraceptives among over-the-counter compared with prescription users.What about clonidine for diarrhoea? A systematic review and meta-analysis of its effect in humansVascular and metabolic effects of sex steroids: new insights into clinical trials.Impact of UK Medical Eligibility Criteria implementation on prescribing of combined hormonal contraceptives.Hormonal contraception in women with migraine: is progestogen-only contraception a better choice?Stroke in women: risk and prevention throughout the lifespan.Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomesMigraine and stroke: current perspectives.Oral contraceptives in migraine.Transdermal estradiol for postpartum depression: a promising treatment option.Migraine and cardiocerebrovascular risk in women.
P2860
Q24187746-FE969EFB-B1E8-4F35-B952-381F4F8509DBQ24796371-DB068952-4AD9-4E79-820A-298B3E18BF31Q24799604-D23B2A50-C206-4B7A-B34E-5D4957A516C2Q26748678-3F10C527-D623-4540-B720-485661DB85A3Q26773369-8E7412A7-B66E-4492-B878-D2255D3A33B9Q26801284-A340E6D7-EF4F-4CF0-92ED-E69B95A8732AQ27012615-E8ADB6A4-3280-4460-9F07-887A36C83CFFQ28393100-D8534D07-C80E-4223-9A76-5874E57253F0Q28535464-1FE0E5B2-1310-461E-8FF6-6DB46BAC6F50Q29547236-3DB2C2EB-7881-4E1B-86B6-582F3B302028Q29547691-D62EECF2-D899-43D2-B9D7-00786A49EE6EQ30238784-1EA06BB8-CBFB-4E69-A7C0-6171F599A514Q30244153-019F1AE6-D460-4D19-9373-10585919E2EAQ31013593-D94E3D50-9788-4270-B730-7FB3EABD28DFQ33566603-E11FB96B-F5CC-4029-A33C-BB57B3193531Q33685081-FCD8B520-E23F-46AF-BA7F-E9B935E29FD8Q33894784-415E1F42-9685-4346-8EB7-C3AFC5B16618Q34072168-40B2014B-40C8-4321-99BC-3C845F635F55Q34254787-404D3BCD-9AFE-4915-834E-B1FEF3EF4505Q34435123-7135A4EE-543F-4CC4-9DA3-682E3A09F54CQ34587344-1D234B53-5A1F-41C9-97A0-9486889AF096Q34977665-077FCABF-FD52-47D6-AAF0-9525B4B3447EQ35001052-41BA3FCD-6108-4AFE-BA6D-59177CF4F2A2Q35236454-A62F829C-D25A-440F-BBFC-77FBD4973283Q35572460-B0B84341-0FDD-416C-9304-BDED3B1384F8Q35760828-0D69BCE6-31CC-4E5A-B140-B2A9F1CD502DQ36226931-AED943F2-D9FA-431C-AB82-F957328708A3Q36459100-2F62FAAE-3DD3-493D-AFA2-5EB39804DE31Q36737281-2E7B78E5-4D50-475A-9530-B724E9AD7215Q36746625-9BAE30A8-5A73-40F6-A608-979E6E7015B5Q36793828-10A83EDA-439A-4A0F-990E-318B4BDDEE4DQ36888620-EC35BE2D-CEAC-4731-B55A-738A58768197Q37012682-0BFFB981-1968-4491-9A01-32C99A6871BAQ37075316-95ECF63C-EE02-42FF-A90F-C50031CCBB31Q37080269-B1F2BA27-46A9-4FA6-BB50-E25B86D2C492Q37149840-457598B9-FD06-4AB6-8379-B6758BE57D73Q37282908-398300A8-2B33-46DC-B289-925F7249B083Q37409501-62D9BC89-43FF-4CC7-B374-4EA80177A3F4Q37435819-A4458C3E-EDE8-4572-99B6-C87DE495F73FQ37608416-71E8D52A-5DCF-477B-B1DB-6FC03231EF08
P2860
Ischemic stroke risk with oral contraceptives: A meta-analysis.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ischemic stroke risk with oral contraceptives: A meta-analysis.
@ast
Ischemic stroke risk with oral contraceptives: A meta-analysis.
@en
type
label
Ischemic stroke risk with oral contraceptives: A meta-analysis.
@ast
Ischemic stroke risk with oral contraceptives: A meta-analysis.
@en
prefLabel
Ischemic stroke risk with oral contraceptives: A meta-analysis.
@ast
Ischemic stroke risk with oral contraceptives: A meta-analysis.
@en
P2093
P356
P1476
Ischemic stroke risk with oral contraceptives: A meta-analysis.
@en
P2093
L A Gillum
S C Johnston
S K Mamidipudi
P356
10.1001/JAMA.284.1.72
P407
P577
2000-07-01T00:00:00Z